Expanding Horizons: A Strategic Guide for European Bioscience Companies Entering China
This article provides a comprehensive overview of the opportunities and challenges European bioscience companies face when expanding into China. It outlines key benefits such as:
- market growth,
- government support, and
- innovation partnerships.
Accompanying the article is a detailed worksheet designed to help companies systematically plan their entry into the Chinese market, covering essential aspects like market research, regulatory compliance, strategic partnerships, and risk management. This guide is an essential resource for bioscience firms looking to capitalize on China’s dynamic healthcare landscape.
Additionally, if you’d like more help. We’ve got the following two options:
- Schedule an intake to explore options to enter the Chinese market
- Promote your company at the big Innomatch Expo in September in China. Let us know and we’ll represent your business there. Here’s what to expect from that expo:
Event Highlights:
– Directing Organisation: Ministry of Science and Technology, PRC, Shanghai Municipal People’s Government
– Sponsor: Department of Achievement Transformation and Regional Innovation, Ministry of Science and Technology
– Achievements:
– 68.1% Supply and Demand Matching Rate
– 10 Billion RMB Proposed Transaction Volume
– 18 Participating Countries
– 2,000+ Exhibitors
– 100 Million Transmission Influence